Tag: proof of concept
Phase II proof-of-concept clinical study of Namilumab for ankylosing spondylitis initiated
Izana Bioscience, a biopharmaceutical company focused on translational medicine, has announced the initiation of a phase II proof-of-concept clinical study of namilumab in ankylosing...